TD SYNNEX (SNX) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
31 Mar, 2026Strategic positioning and growth drivers
Global leader with sustainable competitive advantages and a large addressable market.
Diversified business model with strong customer and vendor relationships.
Focus on extending reach, broadening capabilities, and growing faster than the market.
Experienced management team committed to shareholder value and disciplined execution.
Significant cash flow generation and high return on invested capital.
Financial performance and targets
Non-GAAP diluted EPS growth targeted at 10–12%+ through improved mix and cost management.
Non-GAAP net income to free cash flow conversion consistently above 95%.
Medium-term aspirations include 5%+ non-GAAP gross billings CAGR and 95%+ net income to FCF conversion.
Proven track record: $2.0B non-GAAP operating income (+9% CAGR), $15.13 non-GAAP diluted EPS (+14% CAGR), $3.7B FCF FY23–FY25.
Q1 FY26 non-GAAP gross billings up 24% year-over-year; Hyve Solutions up 95%.
Capital allocation and shareholder returns
Targeting 50–75% return of free cash flow to shareholders via dividends and buybacks.
$2.5B in cumulative post-merger shareholder returns, 78% through share repurchases.
Average share repurchase price to date: $110.
Disciplined M&A to accelerate strategy and enhance returns.
Maintaining investment grade rating and liquidity to support growth and M&A.
Latest events from TD SYNNEX
- Record Q1 FY26 growth and strong Q2 outlook driven by robust demand and operational execution.SNX
Q1 202631 Mar 2026 - Strong growth in IT distribution and cloud infrastructure drives robust earnings and shareholder returns.SNX
Company presentation31 Mar 2026 - Key votes include director elections, say-on-pay, auditor ratification, and a charter amendment.SNX
Proxy Filing13 Feb 2026 - Proxy covers director elections, say-on-pay, auditor ratification, and ESG progress.SNX
Proxy Filing13 Feb 2026 - Board seeks approval for director elections, executive pay, auditor ratification, and expanded shareholder rights.SNX
Proxy Filing3 Feb 2026 - Q2 delivered 3% gross billings growth, margin gains, and strong shareholder returns.SNX
Q2 20243 Feb 2026 - Q3 non-GAAP gross billings up 9% to $20.3B; revenue $14.7B; Q4 outlook strong.SNX
Q3 202420 Jan 2026 - Q4 revenue rose 10% with strong cash flow, robust capital returns, and a higher dividend.SNX
Q4 202410 Jan 2026 - Record Q4 and FY results with 15% billings growth, 24% EPS gain, and strong FY26 outlook.SNX
Q4 20258 Jan 2026